Streetbeat News

Stock Prices

MRVL

Marvell Technology's stock price increased following Oppenheimer's reiteration of an Outperform rating and a raised price target from $70 to $80.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 6:00 pm

ELV

Elevance Health (NYSE:ELV) has delivered an impressive average annual return of 18.49% over the past 10 years, outperforming the market by 8.05% on an annualized basis. An initial investment of $1000 in ELV stock a decade ago would be worth $5,501.60 today, showcasing the significant impact of compounded returns on investment growth. Elevance Health currently boasts a market capitalization of $116.24 billion.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 6:00 pm

HRB

H&R Block (NYSE:HRB) has delivered an average annual return of 15.51% over the past 5 years, outperforming the market by 2.83% on an annualized basis. With a current market capitalization of $6.94 billion, an initial investment of $1000 in HRB stock 5 years ago would be worth $2,052.65 today.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 6:00 pm

LPSN

LivePerson shares dropped following mixed Q4 financial results and lower-than-expected revenue guidance for Q1 and 2024. The company's projections fell short of analyst estimates, impacting investor sentiment.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 5:58 pm

BUD

Anheuser-Busch's shares dropped following a report of lower-than-expected Q4 revenue, along with a decline in total and own beer volumes.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 5:55 pm

DOGEUSD

SHIBUSD

Shiba Inu (CRYPTO: SHIB) surged over 15% following the announcement of a new privacy-focused network on the Shibarium blockchain in partnership with Zama. This network utilizes Fully Homomorphic Encryption and is supported by the Shiba Inu ecosystem token TREAT. The Shibarium network aims to offer low-fee financial services and gaming. Significant increases in new accounts and large transactions indicate strong buying activity. Analyst Altcoin Sherpa predicts potential huge runs for both Dogecoin (CRYPTO: DOGE) and Shiba Inu, highlighting their promising charts.

Portfolio Pulse from Khyathi Dalal

February 29, 2024 | 5:54 pm

RNLX

Renalytix plc (NASDAQ:RNLX) announced the U.S. Government's approval to add its kidneyintelX.dkd test to a 10-year Governmentwide Acquisition Contract for early-stage kidney disease testing, effective March 1, 2024. The test is priced at $950 per result. This contract allows for testing services at any government healthcare facility, including the U.S. Veterans Administration and Department of Defense. Additionally, Medicare's consideration of a coverage policy for KidneyIntelX could lead to insurance reimbursement for millions of patients. RNLX shares surged 32.50% to $1.10.

Portfolio Pulse from Vandana Singh

February 29, 2024 | 5:51 pm

RXST

Stifel analyst Thomas Stephan has maintained a Buy rating on RxSight (NASDAQ:RXST) and increased the price target from $54 to $64. This adjustment reflects a positive outlook on RxSight's stock performance.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 5:46 pm

ROKU

Financial analysis reveals a bearish sentiment among traders on Roku (NASDAQ:ROKU), with 59% showing bearish tendencies in recent options activity. The analysis highlighted 27 unusual trades, with a significant portion being calls. The price window eyed by traders ranges from $20.0 to $110.0. Roku, a leading streaming platform, is currently trading up by 1.74% at $64.82, with potential oversold conditions indicated by RSI readings. The company's earnings release is anticipated in 55 days.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 5:46 pm

MSFT

OKTA

Okta Inc (NASDAQ:OKTA) shares surged after reporting strong Q4 results, with several analysts raising their price targets. The company's performance was highlighted by robust growth and minimal impact from a recent security breach. Analysts remain optimistic about Okta's positioning in the identity management market despite increasing competition, particularly from Microsoft Corp (NASDAQ:MSFT).

Portfolio Pulse from Priya Nigam

February 29, 2024 | 5:45 pm